Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies.
King AA, Kamani N, Bunin N, Sahdev I, Brochstein J, Hayashi RJ, Grimley M, Abraham A, Dioguardi J, Chan KW, Douglas D, Adams R, Andreansky M, Anderson E, Gilman A, Chaudhury S, Yu L, Dalal J, Hale G, Cuvelier G, Jain A, Krajewski J, Gillio A, Kasow KA, Delgado D, Hanson E, Murray L, Shenoy S. King AA, et al. Among authors: gilman a. Am J Hematol. 2015 Dec;90(12):1093-8. doi: 10.1002/ajh.24183. Epub 2015 Oct 6. Am J Hematol. 2015. PMID: 26348869 Free article.
Long-Term Follow-Up after Reduced-Intensity Conditioning and Stem Cell Transplantation for Childhood Nonmalignant Disorders.
Madden LM, Hayashi RJ, Chan KW, Pulsipher MA, Douglas D, Hale GA, Chaudhury S, Haut P, Kasow KA, Gilman AL, Murray LM, Shenoy S. Madden LM, et al. Among authors: gilman al. Biol Blood Marrow Transplant. 2016 Aug;22(8):1467-1472. doi: 10.1016/j.bbmt.2016.04.025. Epub 2016 May 6. Biol Blood Marrow Transplant. 2016. PMID: 27164064 Free article.
Response to: "Technology and Long-Term Health-Related Quality-of-Life Outcomes in Children with Nonmalignant Disorders after Reduced-Intensity Conditioning and Stem Cell Transplantation".
Madden LM, Hayashi RJ, Chan KW, Pulsipher MA, Douglas D, Hale GA, Chaudhury S, Haut P, Kasow KA, Gilman AL, Murray LM, Shenoy S. Madden LM, et al. Among authors: gilman al. Biol Blood Marrow Transplant. 2016 Sep;22(9):1734. doi: 10.1016/j.bbmt.2016.06.013. Epub 2016 Jun 22. Biol Blood Marrow Transplant. 2016. PMID: 27343717 Free article. No abstract available.
Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease.
Shah NC, Bhoopatiraju S, Abraham A, Anderson E, Andreansky M, Bhatia M, Chaudhury S, Cuvelier GDE, Godder K, Grimley M, Hale G, Kamani N, Jacobsohn D, Ngwube A, Gilman AL, Skiles J, Yu LC, Shenoy S. Shah NC, et al. Among authors: gilman al. Transplant Cell Ther. 2022 Mar;28(3):174.e1-174.e5. doi: 10.1016/j.jtct.2021.12.016. Epub 2021 Dec 24. Transplant Cell Ther. 2022. PMID: 34958973 Free article. Clinical Trial.
Cardiac manifestations of graft-versus-host disease.
Rackley C, Schultz KR, Goldman FD, Chan KW, Serrano A, Hulse JE, Gilman AL. Rackley C, et al. Among authors: gilman al. Biol Blood Marrow Transplant. 2005 Oct;11(10):773-80. doi: 10.1016/j.bbmt.2005.07.002. Biol Blood Marrow Transplant. 2005. PMID: 16182178 Free article.
Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031.
Cuvelier GD, Kariminia A, Fujii H, Aslanian S, Wall D, Goldman F, Grupp SA, Dunn SE, Krailo M, Shapiro LH, Gilman A, Schultz KR. Cuvelier GD, et al. Among authors: gilman a. Bone Marrow Transplant. 2010 Nov;45(11):1653-7. doi: 10.1038/bmt.2010.15. Epub 2010 Mar 1. Bone Marrow Transplant. 2010. PMID: 20190833 Free PMC article. Clinical Trial.
Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.
Fujii H, Cuvelier G, She K, Aslanian S, Shimizu H, Kariminia A, Krailo M, Chen Z, McMaster R, Bergman A, Goldman F, Grupp SA, Wall DA, Gilman AL, Schultz KR. Fujii H, et al. Among authors: gilman al. Blood. 2008 Mar 15;111(6):3276-85. doi: 10.1182/blood-2007-08-106286. Epub 2007 Oct 9. Blood. 2008. PMID: 17925486 Free PMC article.
Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study.
Jacobsohn DA, Gilman AL, Rademaker A, Browning B, Grimley M, Lehmann L, Nemecek ER, Thormann K, Schultz KR, Vogelsang GB. Jacobsohn DA, et al. Among authors: gilman al. Blood. 2009 Nov 12;114(20):4354-60. doi: 10.1182/blood-2009-05-224840. Epub 2009 Sep 10. Blood. 2009. PMID: 19745067 Free article. Clinical Trial.
Hydroxychloroquine for the treatment of chronic graft-versus-host disease.
Gilman AL, Chan KW, Mogul A, Morris C, Goldman FD, Boyer M, Cirenza E, Mazumder A, Gehan E, Cahill R, Frankel S, Schultz K. Gilman AL, et al. Biol Blood Marrow Transplant. 2000;6(3A):327-34. doi: 10.1016/s1083-8791(00)70058-9. Biol Blood Marrow Transplant. 2000. PMID: 10905770 Free article. Clinical Trial.
533 results